- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Theralase Anti-Cancer Technology Effective for the Destruction of Lung Cancer
Theralase Technologies announced its lead compound TLD-1433 in a combination with Rutherrin showed an ability to eliminate different versions of lung cancer.
Theralase Technologies (TSXV:TLT; OTCQX:TLTFF) announced its lead compound TLD-1433 in a combination with Rutherrin showed an ability to eliminate different versions of lung cancer.
As quoted in the press release:
TLD-1433, in combination with transferrin (RutherrinĀ®) has been shown to selectively accumulate in cancerous tumors versus healthy tissue, due to localization through the Tf-R.
Each type of NSCLC has different kinds of cancer cells. The cancer cells of each type grow and spread in different ways. The types of NSCLC are named for the kinds of cells found in cancer and how the cells look under a microscope:
- Squamous cell carcinoma: Cancer that begins in squamous cells, which are thin, flat cells that look like fish scales, also called epidermoid carcinoma.
- Large cell carcinoma: Cancer that may begin in several types of large cells.
- Adenocarcinoma: Cancer that begins in the cells that line the alveoli and produce substances such as mucus.
In preclinical experiments conducted by the team of Kazuhiro Yasufuku MD, PhD, Director of Endoscopy and the Director of Interventional Thoracic Surgery Program in the Division of Thoracic Surgery, Toronto General Hospital, University Health Network (āUHNā), as well as an Associate Professor of Surgery at the University of Toronto, an evaluation of the TfR by flow cytometric analysis in three human cancer cell lines; specifically: H2170 (lung squamous cell carcinoma), H460 (large cell lung cancer carcinoma) and A549 (lung adeno carcinoma) showed almost 100% of lung cancer cells express the TfR.
Click here to read the full press release.
Source: www.accesswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to theĀ cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Ā